Perseverance Research Center, LLC

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials
• Migraine2 trials
• Multiple sclerosis2 trials
• Diabetic foot ulcer1 trial
• Mild cognitive impairment1 trial
• Narcolepsy1 trial

Phase

• Phase 34 trials
• Phase 23 trials
• Phase 41 trial

Status

• Recruiting3 trials
• Active, not recruiting2 trials
• Completed2 trials
• Terminated2 trials

Lead sponsor

• Pfizer2 trials
• AriBio Co., Ltd.1 trial
• Banner Life Sciences LLC1 trial
• Biocomposites Ltd1 trial
• Celgene1 trial
• and 3 more

Running trials

• Recruiting

  A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  NCT06782490· Phase 2· Celgene· Source

  Contact: Barry Hendin, Site 0050

• Active, not recruiting

  A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

  NCT06223360· Phase 2· Weill Medical College of Cornell University· Source

• Active, not recruiting

  Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

  NCT05531526· Phase 3· AriBio Co., Ltd.· Source

• Recruiting

  Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

  NCT04743141· Phase 3· Pfizer· Source

• Recruiting

  Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  NCT04649242· Phase 3· Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Migraine2 recruiting
• Multiple sclerosis1 recruiting

Closed trials

• Terminated

  Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

  NCT05978531· Banner Life Sciences LLC· Source

• Completed

  A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy

  NCT05875974· Phase 4· Jazz Pharmaceuticals· Source

• Completed

  A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis

  NCT05539963· Phase 2· Biocomposites Ltd· Source

• Terminated

  Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

  NCT02446132· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source